Mutual Advisors LLC Sells 300 Shares of iShares Biotechnology ETF (NASDAQ:IBB)

Mutual Advisors LLC lowered its holdings in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 3.1% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 9,300 shares of the financial services provider’s stock after selling 300 shares during the period. Mutual Advisors LLC’s holdings in iShares Biotechnology ETF were worth $1,236,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently bought and sold shares of IBB. Hsbc Holdings PLC lifted its holdings in shares of iShares Biotechnology ETF by 47.1% during the second quarter. Hsbc Holdings PLC now owns 3,670 shares of the financial services provider’s stock valued at $504,000 after acquiring an additional 1,175 shares during the period. AE Wealth Management LLC boosted its position in iShares Biotechnology ETF by 10.7% in the second quarter. AE Wealth Management LLC now owns 2,034 shares of the financial services provider’s stock valued at $279,000 after buying an additional 196 shares in the last quarter. Bank of Montreal Can increased its holdings in shares of iShares Biotechnology ETF by 2.6% during the second quarter. Bank of Montreal Can now owns 36,198 shares of the financial services provider’s stock worth $5,086,000 after buying an additional 920 shares in the last quarter. Creative Planning raised its stake in shares of iShares Biotechnology ETF by 2.9% in the second quarter. Creative Planning now owns 67,902 shares of the financial services provider’s stock valued at $9,320,000 after acquiring an additional 1,905 shares during the last quarter. Finally, NewEdge Advisors LLC boosted its holdings in shares of iShares Biotechnology ETF by 20.1% in the 2nd quarter. NewEdge Advisors LLC now owns 11,633 shares of the financial services provider’s stock worth $1,597,000 after acquiring an additional 1,944 shares in the last quarter. Institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Stock Down 0.7 %

IBB stock opened at $137.30 on Friday. The business has a fifty day moving average price of $136.04 and a 200 day moving average price of $141.80. iShares Biotechnology ETF has a fifty-two week low of $123.60 and a fifty-two week high of $150.57.

iShares Biotechnology ETF Cuts Dividend

The firm also recently declared a dividend, which was paid on Friday, December 20th. Investors of record on Tuesday, December 17th were issued a $0.0624 dividend. The ex-dividend date of this dividend was Tuesday, December 17th.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.